skip to primary navigationskip to content

Cambridge Institute for Medical Research

Department A-Z

Our strategy

We aim to create an inspiring environment in which outstanding scientists can excel. By providing state-of-the-art core facilities and support for our researchers, we foster new collaborations that spark discoveries about fundamental cellular processes and their relevance in disease.

Read more

Research advances

The Rubinsztein lab report in Molecular Cell that phosphatidylinositol 5-phosphate (PI(5)P) promotes autophagosome biogenesis and that it can sustain autophagy when PI(3)P is depleted. This highlights a novel cytoplasmic role for PI(5)P as a regulator of non-canonical autophagy.

Read more

Research advances

The Seaman lab reveal in Cell Reports the findings of their genome-wide siRNA screen for regulators of endosome-to-Golgi retrieval, a process implicated in neurodegenerative disease. Among >80 hits, they find a new role for three multipass membrane-spanning proteins.

Read more

News

Andres Floto discusses in Cambridge News how altering the innate immune system response during infection may help provide improved treatments for conditions such as tuberculosis and cystic fibrosis.

Read more

News

In an interview with Cambridge News, David Rubinsztein outlines research efforts to target the autophagy process as a means of delaying the onset of neurodegenerative disease.

Read more

EMBO interview

David Ron reviews his career choices in the autumn issue of EMBOencounters, as well as his election to the Royal Society and the importance of sustaining public support for science.

Read more

Wellcome-Beit Prize Fellowship

Congratulations to Eoin McKinney in the Smith lab, who has been awarded a Wellcome Trust Intermediate Clinical Fellowship and a Wellcome-Beit Prize Fellowship, the latter of which recognizes just four outstanding biomedical researchers each year.